Novel Drugs for Chronic Lymphoid Leukemias: Mechanism of Action and Therapeutic Activity

E-ISSN： 1875-533x|16|18|2212-2234

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.16, Iss.18, 2009-06, pp. : 2212-2234

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel and Emerging Drugs for Systemic Lupus Erythematosus: Mechanism of Action and Therapeutic Activity

Current Medicinal Chemistry, Vol. 19, Iss. 3, 2012-01 ,pp. : 438-453

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging drugs for rarer chronic lymphoid leukemias

By Robak Tadeusz

Expert Opinion on Emerging Drugs, Vol. 13, Iss. 1, 2008-03 ,pp. : 95-118

Informa Healthcare

Access to resources Recommend Favorite

Novel and Emerging Drugs for Rarer Chronic Lymphoid Leukaemias

Current Cancer Drug Targets, Vol. 12, Iss. 5, 2012-05 ,pp. : 484-504

Bentham Science Publishers

Access to resources Recommend Favorite

Purine Nucleoside Analogs in the Treatment of Rarer Chronic Lymphoid Leukemias

Current Pharmaceutical Design, Vol. 18, Iss. 23, 2012-08 ,pp. : 3373-3388

Bentham Science Publishers

Access to resources Recommend Favorite

Novel and Emerging Drugs for Acute Myeloid Leukemia: Pharmacology and Therapeutic Activity

Current Medicinal Chemistry, Vol. 18, Iss. 5, 2011-02 ,pp. : 638-666

Bentham Science Publishers

Access to resources Recommend Favorite